← Open Payments lookup

ANDREW GULBIS: Open Payments

NPI 1720216443 · TOMBALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,101 in 50 payments from 17 companies in 2025. Trend: 2023 $837 · 2024 $1,220 · 2025 $1,101

Food & beverage: $1,101
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP4$160
Novo Nordisk Inc8$148
HARMONY BIOSCIENCES LLC4$127
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$123
ABBVIE INC.6$113
GlaxoSmithKline, LLC.6$113
Lilly USA, LLC3$56
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$50
Antares Pharma, Inc.2$39
CeQur Corporation1$33

Products named: BREZTRI, WAKIX, CAPLYTA, TRELEGY ELLIPTA, Ozempic, QULIPTA, XIFAXAN, XYOSTED.

Industry payments across TX — which companies pay providers there.